Paula Soteropoulos, Director at Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 27,594 shares at $78.05 ($2.2M) on 2026-03-24, disclosed to the SEC on 2026-03-26.
Scheduled sale ($2.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| QURE | SELL | 2024-06-17 | $11K | — | Filing → |
| QURE | SELL | 2023-06-20 | $43K | — | Filing → |
| QURE | SELL | 2023-03-01 | $8K | — | Filing → |